Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin

In DAPA-HF, elevated IL-6 and hs-CRP levels were each associated with the risk of worsening HF or cardiovascular death. Dapagliflozin reduced the risk of adverse outcomes regardless of baseline IL-6 or hs-CRP. (Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure [DAPA-HF]; NCT03036124).

Authors

Institutions

Publication Details

Journal
JACC Heart Failure
Published
2025-03-12
DOI
https://doi.org/10.1016/j.jchf.2024.12.012
Citations
11
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
14.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin

Inder S. Anand, Kieran F. Docherty, Paul Welsh, Mark C. Petrie et al.
11 citations
JACC Heart Failure
Diabetes Treatment and Management
14.24
article

Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin

Inder S. Anand, Kieran F. Docherty, Paul Welsh, Mark C. Petrie, Piotr Ponikowski, Pardeep S. Jhund, John J.V. McMurray, Eileen O’Meara, Marc S. Sabatine, Mikaela Sjöstrand, Rudolf A. de Boer, Lars Køber, Felipe A. Martínez, David D. Berg, Scott David Solomon, David A. Morrow, Ann Hammarstedt, Naveed A. Sattar, Kirsty McDowell, Mikhail Kosiborod, Morten Schou, Anna Maria Langkilde
article en
11 citations

Abstract

In DAPA-HF, elevated IL-6 and hs-CRP levels were each associated with the risk of worsening HF or cardiovascular death. Dapagliflozin reduced the risk of adverse outcomes regardless of baseline IL-6 or hs-CRP. (Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure [DAPA-HF]; NCT03036124).

JACC Heart FailureVol. 13(7)
University of Copenhagen (DK), Brigham and Women's Hospital (US), Harvard University (US), Montreal Heart Institute (CA), Gentofte Hospital (DK), Rigshospitalet (DK), Wroclaw Medical University (PL), University of Minnesota Medical Center (US), Saint Luke's Hospital (US), AstraZeneca (Sweden) (SE), Erasmus MC Cancer Institute (NL), Thrombolysis in Myocardial Infarction Study Group (US), Université de Montréal (CA), University of Missouri–Kansas City (US), University of Glasgow (GB)
Good health and well-being
Openalex Percentile: Top 1%
Diabetes Treatment and Management
14.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.